Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 30:2022:4973996.
doi: 10.1155/2022/4973996. eCollection 2022.

Neutrophil to Lymphocyte Ratio in Epilepsy: A Systematic Review

Samaneh Hosseini  1 , Amir Mohammad Eghbalnejad Mofrad  2 , Peyman Mokarian  3 , Shima Nourigheimasi  4 , Amir Azarhomayoun  5 , Shokoufeh Khanzadeh  6 , Saba Habibzadeh  7 , Arshin Ghaedi  8
Affiliations

Neutrophil to Lymphocyte Ratio in Epilepsy: A Systematic Review

Samaneh Hosseini et al. Mediators Inflamm. .

Abstract

This study was conducted to summarize the results of studies investigating the role of neutrophil to lymphocyte ratio (NLR) in epilepsy. The search was conducted on PubMed, Scopus, and Web of Science up to December 25, 2021. Finally, a total of seven studies were included in the review. The NLR in patients who were in the acute phase was higher than that of healthy. NLR in the patients who were in either acute or subacute phase was higher than in healthy controls. A significant difference in NLR levels between the acute and subacute phases was also noted. Epilepsy is one of the most important neurological diseases in the world, and millions of people around the world suffer from it, and a cheap and fast biomarker is needed for it. The interesting thing is that inflammation plays a role in epilepsy, and elevated NLR value can be a good biomarker of inflammation and, as a result, for epilepsy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this article.

Figures

Figure 1
Figure 1
PRISMA 2020 flow diagram for new systematic reviews which includes searches of databases, registers, and other sources.
See this image and copyright information in PMC

References

    1. Megiddo I., Colson A., Chisholm D., Dua T., Nandi A., Laxminarayan R. Health and economic benefits of public financing of epilepsy treatment in India: an agent-based simulation model. Epilepsia . 2016;57(3):464–474. doi: 10.1111/epi.13294. - DOI - PMC - PubMed
    1. Saxena S., Li S. Defeating epilepsy: a global public health commitment. Epilepsia open . 2017;2(2):153–155. doi: 10.1002/epi4.12010. - DOI - PMC - PubMed
    1. Moshé S. L., Perucca E., Ryvlin P., Tomson T. Epilepsy: new advances. The Lancet . 2015;385(9971):884–898. doi: 10.1016/S0140-6736(14)60456-6. - DOI - PubMed
    1. Morkavuk G., Koc G., Leventoglu A. Is the differential diagnosis of epilepsy and psychogenic nonepileptic seizures possible by assessing the neutrophil/lymphocyte ratio? Epilepsy & Behavior . 2021;116, article 107736 doi: 10.1016/j.yebeh.2020.107736. - DOI - PubMed
    1. Benini R., Roth R., Khoja Z., Avoli M., Wintermark P. Does angiogenesis play a role in the establishment of mesial temporal lobe epilepsy? International Journal of Developmental Neuroscience . 2016;49(1):31–36. doi: 10.1016/j.ijdevneu.2016.01.001. - DOI - PMC - PubMed

Publication types